CellAegis Announces Completion of Patient Enrollment in Danish Investigator Sponsored Clinical Trial Using autoRIC® Device
17. Mai 2018 07:00 ET
|
CellAegis Devices Inc.
TORONTO, May 17, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and cost-effective...
CellAegis Announces First Distribution Agreement for autoRIC® in Europe
24. April 2018 07:00 ET
|
CellAegis Devices Inc.
TORONTO, April 24, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis”) a commercial-stage medical device company advancing innovative, non-invasive, safe and cost-effective solutions for...
CellAegis Strengthens Management Team to Support Future Growth
17. April 2018 07:00 ET
|
CellAegis Devices Inc.
TORONTO, April 17, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and...
CellAegis Announces First Patients Enrolled in U.S. SHIELD Pivotal Clinical Trial
10. April 2018 07:00 ET
|
CellAegis Devices Inc.
TORONTO, April 10, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and...